Maryam Ajami

491 total citations
14 papers, 395 citations indexed

About

Maryam Ajami is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Maryam Ajami has authored 14 papers receiving a total of 395 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 5 papers in Molecular Biology and 4 papers in Oncology. Recurrent topics in Maryam Ajami's work include Immune cells in cancer (4 papers), Mathematical Biology Tumor Growth (3 papers) and Immune Cell Function and Interaction (3 papers). Maryam Ajami is often cited by papers focused on Immune cells in cancer (4 papers), Mathematical Biology Tumor Growth (3 papers) and Immune Cell Function and Interaction (3 papers). Maryam Ajami collaborates with scholars based in Iran, United States and Canada. Maryam Ajami's co-authors include Jamshid Hadjati, Farhad Jadidi‐Niaragh, Nasim Kheshtchin, Samaneh Arab, Farshid Noorbakhsh, Reza Mirzaei, Ali Rastegari, Fatemeh Atyabi, Afshin Namdar and Fazel Shokri and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Controlled Release and Journal of Cellular Biochemistry.

In The Last Decade

Maryam Ajami

13 papers receiving 390 citations

Peers

Maryam Ajami
Xiao Qin United Kingdom
Israel Cañadas United States
Natalia M. Dworak United States
Tara Lee Costich United States
Anne Showalter United States
Maryam Ajami
Citations per year, relative to Maryam Ajami Maryam Ajami (= 1×) peers Nasim Kheshtchin

Countries citing papers authored by Maryam Ajami

Since Specialization
Citations

This map shows the geographic impact of Maryam Ajami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maryam Ajami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maryam Ajami more than expected).

Fields of papers citing papers by Maryam Ajami

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maryam Ajami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maryam Ajami. The network helps show where Maryam Ajami may publish in the future.

Co-authorship network of co-authors of Maryam Ajami

This figure shows the co-authorship network connecting the top 25 collaborators of Maryam Ajami. A scholar is included among the top collaborators of Maryam Ajami based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maryam Ajami. Maryam Ajami is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Kheshtchin, Nasim, et al.. (2022). Agent-based Modeling of Tumor and Immune System Interactions in Combinational Therapy with Low-dose 5-fluorouracil and Dendritic Cell Vaccine in Melanoma B16F10. Iranian Journal of Allergy Asthma and Immunology. 21(2). 151–166. 6 indexed citations
3.
Ajami, Shabnam, et al.. (2021). Farsi version of the CLEFT-Q: translation, cultural adaptation process and reliability. BMC Oral Health. 21(1). 593–593. 3 indexed citations
4.
Ajami, Maryam, Mahboobeh Nazari, Habibollah Mahmoodzadeh, & Seyed Mohammad Moazzeni. (2021). Recombinant CD137‐Fc, its synthesis, and applications for improving the immune system functions, such as tumor immunotherapy and to reduce the inflammation due to the novel coronavirus. Journal of Cellular Biochemistry. 122(9). 1072–1084. 2 indexed citations
5.
Mohammadi, Mohammad Mahdi, et al.. (2019). Sodium Butyrate as a Histone Deacetylase Inhibitor Affects Toll-Like Receptor 4 Expression in Colorectal Cancer Cell Lines. Immunological Investigations. 48(7). 759–769. 17 indexed citations
7.
Esmaeili, Rezvan, Reza Mirzaei, Katayoon Bidad, et al.. (2017). Study of the tumor microenvironment during breast cancer progression. Cancer Cell International. 17(1). 123–123. 27 indexed citations
8.
Arab, Samaneh, Nasim Kheshtchin, Maryam Ajami, et al.. (2017). Increased efficacy of a dendritic cell–based therapeutic cancer vaccine with adenosine receptor antagonist and CD73 inhibitor. Tumor Biology. 39(3). 3726131102–3726131102. 53 indexed citations
9.
Jafari‬, Amir Homayoun, Jamshid Hadjati, Hamid Reza Mirzaei, et al.. (2017). A Predictive Approach for the Tumor-Immune System Interactions Based on an Agent Based Modeling. 2(4). 214–226. 1 indexed citations
10.
Kheshtchin, Nasim, Samaneh Arab, Maryam Ajami, et al.. (2016). Inhibition of HIF-1α enhances anti-tumor effects of dendritic cell-based vaccination in a mouse model of breast cancer. Cancer Immunology Immunotherapy. 65(10). 1159–1167. 76 indexed citations
11.
Jadidi‐Niaragh, Farhad, Fatemeh Atyabi, Ali Rastegari, et al.. (2016). CD73 specific siRNA loaded chitosan lactate nanoparticles potentiate the antitumor effect of a dendritic cell vaccine in 4T1 breast cancer bearing mice. Journal of Controlled Release. 246. 46–59. 151 indexed citations
12.
Shams, Ali, et al.. (2015). Effects of fennel, asafetida and ginseng ethanolic extracts on growth and proliferation of mouse breast cancer 4T1 cell lines. SHILAP Revista de lepidopterología.
13.
Mohammadi, Mohammad Mahdi, et al.. (2015). The Cytotoxicity of a Short Chain Fatty Acid Histone Deacetylase Inhibitor on HCT116 Human Colorectal Carcinoma Cell Line. 1(9). 1 indexed citations
14.
Namdar, Afshin, Hamid Reza Mirzaei, Farhad Jadidi‐Niaragh, et al.. (2015). Multiple Low Doses of 5-Fluorouracil Diminishes Immunosuppression by Myeloid Derived Suppressor Cells in Murine Melanoma Model.. PubMed. 12(3). 176–87. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026